Dasatinib - Sprycel tablet | Apple pharmaceuticals

DASATINIB

Dasatinib is used to treat a certain type of chronic myeloid leukemia. (CML; a type of cancer of the 

white blood cells) as a first treatment and in people who can no longer benefit from other leukemia 

medications including imatinib (Gleevec) or in those who cannot take these medications because of side effects.

The Brands are Available in  Dasatinib

1.Sprycel-20mg

2.Sprycel-50mg

3.Sprycel-70mg

Drug Type :

SPRYCEL is a targeted therapy. SPRYCEL is classified as a signal transduction inhibitor - tyrosine kinase inhibitor..

About Dasatinib : 

This medicine could also cause a sudden and significant fall in the count of white blood cells, red blood cells, or platelets, so you will be advised to assess your blood cell counts once every week for the first two months, and then once a month after that.

Indication of  Dasatinib :

For the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy. Also indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to prior therapy.

Dasatinib Precautions : 

SPRYCEL interacts with many common medications. Be sure to notify your doctor before starting any new medications.

Do not receive any kind of immunization or vaccination without your doctor’s approval while taking SPRYCEL.

Dasatinib may harm the fetus.

Do not breastfeed while taking dasatinib and for 2 weeks after your final dose.

For more Information : 

Call us :  +91- 9987711567

Mail to : applepharmaceutical@gmail.com

Domain :  http://anti-cancer-drugs.com/dasatinib.php